Literature DB >> 17033821

An improved RT-PCR method for the detection of killer-cell immunoglobulin-like receptor (KIR) transcripts.

A Thompson1, A R van der Slik, F Koning, J van Bergen.   

Abstract

Killer cell immunoglobulin-like receptors (KIRs) are expressed on human natural killer (NK) cells and a proportion of T cells. As the specificity of these NK and T cells is, at least in part, determined by the combination of KIRs they express, it is important to be able to determine the KIR expression pattern of NK and T cell clones to understand their function. However, for most KIR genes, specific reagents to detect expression are currently either unavailable or sensitive to allelic variations. In this study, a reverse transcriptase-polymerase chain reaction (RT-PCR) that uses new primer sets for the gene-specific detection of KIR transcripts is presented and validated. The key advantage of this RT-PCR method over previously published ones is that it was designed to detect transcripts of all confirmed allelic variants of the KIR genes, while remaining gene-specific.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17033821     DOI: 10.1007/s00251-006-0163-9

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  45 in total

1.  Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.

Authors:  K A Crum; S E Logue; M D Curran; D Middleton
Journal:  Tissue Antigens       Date:  2000-10

Review 2.  MHC class I molecules and KIRs in human history, health and survival.

Authors:  Peter Parham
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

3.  KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains.

Authors:  C Vilches; R Rajalingam; M Uhrberg; C M Gardiner; N T Young; P Parham
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

4.  Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.

Authors:  C M Gardiner; L A Guethlein; H G Shilling; M Pando; W H Carr; R Rajalingam; C Vilches; P Parham
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

5.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

6.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

7.  Investigation of killer cell immunoglobulin-like receptor gene diversity V. KIR3DL2.

Authors:  A Meenagh; F Williams; C Sleator; I A Halfpenny; D Middleton
Journal:  Tissue Antigens       Date:  2004-09

8.  Killer cell Ig-like receptor and leukocyte Ig-like receptor transgenic mice exhibit tissue- and cell-specific transgene expression.

Authors:  Danny Belkin; Michaela Torkar; Chiwen Chang; Roland Barten; Mauro Tolaini; Anja Haude; Rachel Allen; Michael J Wilson; Dimitris Kioussis; John Trowsdale
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

9.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

Authors:  A Moretta; S Sivori; M Vitale; D Pende; L Morelli; R Augugliaro; C Bottino; L Moretta
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

10.  Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success.

Authors:  Susan E Hiby; James J Walker; Kevin M O'shaughnessy; Christopher W G Redman; Mary Carrington; John Trowsdale; Ashley Moffett
Journal:  J Exp Med       Date:  2004-10-11       Impact factor: 14.307

View more
  4 in total

1.  Differential RNA expression of KIR alleles.

Authors:  Colum McErlean; Asensio A Gonzalez; Rodat Cunningham; Ashley Meenagh; Tanya Shovlin; Derek Middleton
Journal:  Immunogenetics       Date:  2010-05-08       Impact factor: 2.846

2.  Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes.

Authors:  Cristina Gattazzo; Antonella Teramo; Marta Miorin; Elisa Scquizzato; Anna Cabrelle; Mirna Balsamo; Carlo Agostini; Elena Vendrame; Monica Facco; Maria Paola Albergoni; Livio Trentin; Massimo Vitale; Gianpietro Semenzato; Renato Zambello
Journal:  Haematologica       Date:  2010-04-21       Impact factor: 9.941

3.  NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease.

Authors:  Erin M Sullivan; Sima Jeha; Guolian Kang; Cheng Cheng; Barbara Rooney; Martha Holladay; Rafijul Bari; Sarah Schell; MaCal Tuggle; Ching-Hon Pui; Wing Leung
Journal:  Clin Cancer Res       Date:  2014-10-03       Impact factor: 12.531

4.  Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.

Authors:  SungWon Song; Carlos J Miranda; Lyndsey Braun; Kathrin Meyer; Ashley E Frakes; Laura Ferraiuolo; Shibi Likhite; Adam K Bevan; Kevin D Foust; Michael J McConnell; Christopher M Walker; Brian K Kaspar
Journal:  Nat Med       Date:  2016-02-29       Impact factor: 53.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.